Human papillomavirus testing in women with mild cytologic atypia

Obstetrics and Gynecology

Volumn 95, Issue 6, 2000, Pages 821-827

  Bergeron, Christine ^a   Jeannel, Dominique ^a   Poveda, Jean Dominique ^a   Cassonnet, Patricia ^a   Orth, Gérard ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; COLPOSCOPY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; RNA PROBE; SENSITIVITY AND SPECIFICITY; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

BLOTTING, SOUTHERN; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RNA PROBES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034199878     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00795-X     Document Type: Article

References (32)

1. Flannelly G, Anderson D, Kitchener HC, Mann EM, Campbell M, Fisher P, et al. Management of women with mild and moderate cervical dyskaryosis. BMJ 1994;308:1399-403.
2. Jones DE, Creasman WT, Dombroski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987;157:544-9.
3. Nyirjesy I, Billingsley FS, Forman MR. Evaluation of atypical and low-grade cervical cytology in private practice. Obstet Gynecol 1998;92:601-7.
4. Pearlstone AC, Grigsby PW, Mutch DG. High rates of atypical cervical cytology: Occurrence and clinical significance. Obstet Gynecol 1992;80:191-5.
5. Shafi MI. Management of women with mild dyskaryosis. Cytological surveillance avoids overtreatment. BMJ 1994;309:590-1.
6. Sherlaw-Johnson C, Gallivan S, Jenkins D, Jones MH. Cytological screening and management of abnormalities in prevention of cervical cancer: An overview with stochastic modelling. J Clin Pathol 1994;47:430-5.
7. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-6.
8. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
9. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia: Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 1992;16:641-9.
10. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
11. Lörincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
12. Schiffman MH, Bauer HM, Hoover RN, Glass AC, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
13. Lazar JG, Cullen AP, Mielzynska I, Meijide MG, Lörincz AT. Hybrid Capture®: A sensitive signal amplification-based chemiluminescent test for the detection and quantitation of human viral and bacterial pathogens. J Clin Ligand Assay 1999;22:139-51.
14. Walboomers JMM, Jacobs MV, van Oostveen JW, van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections and possible clinical implications. In: Gross G, Von Krogh G, eds. Human papillomavirus infections in dermatovenereology. Boca Raton, Florida: CRC Press, 1997:341-64.
15. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
16. Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papillomavirus testing for intermediate and high-risk types as triage before colposcopy. Am J Obstet Gynecol 1995;172:1150-7.
17. Cox JT, Lörincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
18. Wright TC, Lörincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998;178:962-6.
19. Hall S, Lörincz A, Shah F, Sherman ME, Abbas F, Paull G, et al. Human papillomavirus DNA detection in cervical specimens by Hybrid Capture: Correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996;62:353-9.
20. Bollen LJM, Tjong-A-Hung SP, van der Velden J, Brouwer K, Mol BW, ten Kate FJW, et al. Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: A possible method for selecting patients for colposcopy. Am J Obstet Gynecol 1997;177:548-53.
21. Kaufman RH, Adam E. Is human papillomavirus testing of value in clinical practice? Am J Obstet Gynecol 1999;180:1049-53.
22. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265: 472-7.
23. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998;159:86-90.
24. Shall KV, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and Hybrid Capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol 1997;35:517-9.
25. Clavel C, Masure M, Putaud I, Thomas I, Bory JP, Gabriel R, et al. Hybrid Capture II, a new sensitive test for human papillomavirus detection. Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol 1998;51:737-740.
26. Peyton CL, Schiffman M, Lörincz AT, Hunt WC, Miclzynska I, Bratti C, et al. Comparison of PCR- and Hybrid Capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998;36:248-54.
27. Ferris DG, Wright TC, Litaker MS, Richart RM, Lörincz AT, Sun X-W, et al. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract 1998;46:136-41.
28. Polaak M, Brencic A, Seme K, Vince A, Marin IJ. Comparative evaluation of first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 1999;37:796-7.
29. Schiffman MH, Bauer HM, Lörincz AT, Manos MM, Byrne JC, Glass AG, et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991;29:573-7.
30. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-10.
31. Brown AD, Garber AM. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 1999;281:347-53.
32. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: Interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994;11:390-6.